Clinical Trial Update: Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study [Phase 2]

View source ↗

Summary

Phase 2 study of docetaxel/cisplatin/5-fluorouracil for HPV-positive head and neck squamous cell carcinoma was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma of the Head and Neck, Human Papilloma Virus | Phase 2 | Status: TERMINATED | Results posted: 2016-12-06